ישראל - עברית - Ministry of Health

novartis israel ltd - pazopanib as hydrochloride - טבליות מצופות פילם - pazopanib as hydrochloride 400 mg - pazopanib - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

ישראל - עברית - Ministry of Health

3m israel - articaine hydrochloride; epinephrine hydrochloride - תמיסה להזרקה - epinephrine hydrochloride 0.006 mg/ml; articaine hydrochloride 40 mg/ml - articaine - articaine - infiltration anesthesia and nerve-block in dentistry. ubistesin is especially indicated for routine interventions such as: uncomplicated single and serial extractions. cavity and coronal stump preparations.

ישראל - עברית - Ministry of Health

3m israel - articaine hydrochloride; epinephrine hydrochloride - תמיסה להזרקה - epinephrine hydrochloride 0.012 mg/ml; articaine hydrochloride 40 mg/ml - articaine - articaine - infiltration anesthesia and nerve-block in dentistry. ubistesin is especially indicated for interventions requiring deep anesthesia and pronounced restriction of blood flow such as: - gingival and bone surgery - pulp surgery (amputation and extirpation) - extraction and trepanation of desmotic teeth and extraction of fractured teeth (osteotomy) - protracted surgical procedures i.e. caldwell-luc operation percutaneous osteosynthesis cystectomy mucogingival operations apicectomy.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - טבליות בשחרור ממושך - oxycodone hydrochloride 10 mg; naloxone hydrochloride (as dihydrate) 5 mg - naloxone - naloxone - targin is indicated for the relief of moderate to severe pain.the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut

ישראל - עברית - Ministry of Health

rafa laboratories ltd - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - טבליות בשחרור ממושך - oxycodone hydrochloride 20 mg; naloxone hydrochloride (as dihydrate) 10 mg - naloxone - naloxone - targin is indicated for the relief of moderate to severe pain.the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut

ישראל - עברית - Ministry of Health

rafa laboratories ltd - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - טבליות בשחרור ממושך - oxycodone hydrochloride 5 mg; naloxone hydrochloride (as dihydrate) 2.5 mg - naloxone - naloxone - targin is indicated for the relief of moderate to severe pain.the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - טבליות בשחרור ממושך - naloxone hydrochloride (as dihydrate) 20 mg; oxycodone hydrochloride 40 mg - naloxone - naloxone - targin is indicated for the relief of moderate to severe pain.the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around-the-clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut

ישראל - עברית - Ministry of Health

sam-on ltd - cyanocobalamin; pyridoxine (vit b6) hydrochloride; thiamine (vit b1) hydrochloride - טבליה - pyridoxine (vit b6) hydrochloride 250 mg; thiamine (vit b1) hydrochloride 100 mg; cyanocobalamin 250 mcg - pyridoxine (vit b6) - vitamin b1 in combimation with vitamin b6 and/or vitamin b12 - for the treatment of neurologic pain and metabolic disorders. vitamin b supplement.

ישראל - עברית - Ministry of Health

eli lilly israel ltd - prasugrel as hydrochloride - טבליות מצופות פילם - prasugrel as hydrochloride 5 mg - platelet aggregation inhibitors, excl. heparin - effient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi] undergoing primary or delayed percutaneous coronary intervention (pci).the increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had tia/cva in the past and in those above the age of 75 and a weight below 60 kg3.

ישראל - עברית - Ministry of Health

eli lilly israel ltd - prasugrel as hydrochloride - טבליות מצופות פילם - prasugrel as hydrochloride 10 mg - platelet aggregation inhibitors, excl. heparin - effient, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-st segment elevation myocardial infarction [ua/nstemi] or st segment elevation myocardial infarction [stemi] undergoing primary or delayed percutaneous coronary intervention (pci). the increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had tia/cva in the past and in those above the age of 75 and a weight below 60 kg3.